1. Home
  2. VSME vs XRTX Comparison

VSME vs XRTX Comparison

Compare VSME & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSME
  • XRTX
  • Stock Information
  • Founded
  • VSME 2013
  • XRTX 2011
  • Country
  • VSME Hong Kong
  • XRTX Canada
  • Employees
  • VSME N/A
  • XRTX N/A
  • Industry
  • VSME
  • XRTX Pharmaceuticals and Biotechnology
  • Sector
  • VSME
  • XRTX Health Care
  • Exchange
  • VSME Nasdaq
  • XRTX Nasdaq
  • Market Cap
  • VSME 4.2M
  • XRTX 5.0M
  • IPO Year
  • VSME 2023
  • XRTX N/A
  • Fundamental
  • Price
  • VSME $1.16
  • XRTX $1.33
  • Analyst Decision
  • VSME
  • XRTX Strong Buy
  • Analyst Count
  • VSME 0
  • XRTX 1
  • Target Price
  • VSME N/A
  • XRTX $14.00
  • AVG Volume (30 Days)
  • VSME 476.4K
  • XRTX 22.7K
  • Earning Date
  • VSME 11-26-2024
  • XRTX 11-29-2024
  • Dividend Yield
  • VSME N/A
  • XRTX N/A
  • EPS Growth
  • VSME N/A
  • XRTX N/A
  • EPS
  • VSME N/A
  • XRTX N/A
  • Revenue
  • VSME $7,991,103.00
  • XRTX N/A
  • Revenue This Year
  • VSME N/A
  • XRTX N/A
  • Revenue Next Year
  • VSME N/A
  • XRTX N/A
  • P/E Ratio
  • VSME N/A
  • XRTX N/A
  • Revenue Growth
  • VSME N/A
  • XRTX N/A
  • 52 Week Low
  • VSME $0.65
  • XRTX $1.09
  • 52 Week High
  • VSME $6.26
  • XRTX $7.00
  • Technical
  • Relative Strength Index (RSI)
  • VSME 44.45
  • XRTX 41.92
  • Support Level
  • VSME $1.10
  • XRTX $1.29
  • Resistance Level
  • VSME $1.62
  • XRTX $1.42
  • Average True Range (ATR)
  • VSME 0.21
  • XRTX 0.15
  • MACD
  • VSME -0.05
  • XRTX -0.01
  • Stochastic Oscillator
  • VSME 23.33
  • XRTX 18.75

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a global network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fanbases on social media platforms. The company's business provides value to two major business stakeholders: Creators and Brands. Its Value to Creators: It empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content. Its Value to Brands: the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content strategy and budget and recommending specific Creators.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

Share on Social Networks: